North America Strengthens Its Position in the Cell Line Development Market Growing at 13.3% CAGR
The Cell Line Development Market in North America is gaining momentum as pharmaceutical manufacturers, biotechnology companies, and research institutions increasingly adopt mammalian and microbial cell lines for biopharmaceutical production, drug discovery, and biological research. Market Overview The cell line development market was valued at US$ 6.86 billion in 2023 and is expected to reach...
0 Comments 0 Shares 255 Views 0 Reviews
Sponsored
Sponsored